These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34786845)

  • 1. CD47- and Integrin α4/β1-Comodified-Macrophage-Membrane-Coated Nanoparticles Enable Delivery of Colchicine to Atherosclerotic Plaque.
    Li Y; Che J; Chang L; Guo M; Bao X; Mu D; Sun X; Zhang X; Lu W; Xie J
    Adv Healthc Mater; 2022 Feb; 11(4):e2101788. PubMed ID: 34786845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-κB/NLRP3 pathways in inflammatory endothelial cells.
    Tang J; Li T; Xiong X; Yang Q; Su Z; Zheng M; Chen Q
    J Nanobiotechnology; 2023 Nov; 21(1):460. PubMed ID: 38037046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications.
    Wang Y; Zhang K; Li T; Maruf A; Qin X; Luo L; Zhong Y; Qiu J; McGinty S; Pontrelli G; Liao X; Wu W; Wang G
    Theranostics; 2021; 11(1):164-180. PubMed ID: 33391468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect.
    Sha X; Dai Y; Chong L; Wei M; Xing M; Zhang C; Li J
    J Nanobiotechnology; 2022 Dec; 20(1):506. PubMed ID: 36456996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonodynamic Therapy Promotes Efferocytosis via CD47 Down-Regulation in Advanced Atherosclerotic Plaque.
    Cao Y; Yao J; Gao W; Cao Z; Diabakte K; Wang L; Sun X; Tian Y
    Int Heart J; 2022 Jan; 63(1):131-140. PubMed ID: 35034916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
    Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
    Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Chemically Modified Carbon-Coated Iron Nanoparticles on the Structure of Human Atherosclerotic Plaques Ex Vivo and on Adipose Tissue in Chronic Experiment In Vivo.
    Akhmedov S; Afanasyev S; Beshchasna N; Trusova M; Stepanov I; Rebenkova M; Poletykina E; Vecherskiy Y; Tverdokhlebov S; Bolbasov E; Balakin S; Opitz J; Yermakov A; Kozlov B
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of LOX-1 siRNA and statin to endothelial cells and macrophages in the atherosclerotic lesions by a dual-targeting core-shell nanoplatform: A dual cell therapy to regress plaques.
    Zhao Y; Gao H; He J; Jiang C; Lu J; Zhang W; Yang H; Liu J
    J Control Release; 2018 Aug; 283():241-260. PubMed ID: 29885417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Membrane-Coated Nanocarriers Targeting Plaques to Deliver Anti-CD47 Antibody for Atherosclerotic Therapy.
    Chen L; Zhou Z; Hu C; Maitz MF; Yang L; Luo R; Wang Y
    Research (Wash D C); 2022; 2022():9845459. PubMed ID: 35118420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.
    Lewis DR; Petersen LK; York AW; Zablocki KR; Joseph LB; Kholodovych V; Prud'homme RK; Uhrich KE; Moghe PV
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2693-8. PubMed ID: 25691739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of atherosclerotic target anti-CD47 functionalized by nano-polyelectrolyte complexes between chitosan and hyaluronic acid and in vivo and in vitro targeting experiments.
    Yu J; Ruan Q; Nie X
    Adv Clin Exp Med; 2020 Dec; 29(12):1407-1415. PubMed ID: 33389831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scavenger receptor-targeted plaque delivery of microRNA-coated nanoparticles for alleviating atherosclerosis.
    Bai Q; Xiao Y; Hong H; Cao X; Zhang L; Han R; Lee LKC; Xue EY; Tian XY; Choi CHJ
    Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2201443119. PubMed ID: 36122215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 15. HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages.
    Sanchez-Gaytan BL; Fay F; Lobatto ME; Tang J; Ouimet M; Kim Y; van der Staay SE; van Rijs SM; Priem B; Zhang L; Fisher EA; Moore KJ; Langer R; Fayad ZA; Mulder WJ
    Bioconjug Chem; 2015 Mar; 26(3):443-51. PubMed ID: 25650634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice.
    Gutiérrez-Muñoz C; Méndez-Barbero N; Svendsen P; Sastre C; Fernández-Laso V; Quesada P; Egido J; Escolá-Gil JC; Martín-Ventura JL; Moestrup SK; Blanco-Colio LM
    FASEB J; 2020 Nov; 34(11):14960-14976. PubMed ID: 32924185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
    Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
    Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
    [No Abstract]   [Full Text] [Related]  

  • 18. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis.
    Chen W; Schilperoort M; Cao Y; Shi J; Tabas I; Tao W
    Nat Rev Cardiol; 2022 Apr; 19(4):228-249. PubMed ID: 34759324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.